Article
Interaction between NUDT15 and ABCC4 variants enhances intolerability of 6-mercaptopurine in Japanese patients with childhood acute lymphoblastic leukemia.
The pharmacogenomics journal - 1 Apr 2018
Tanaka Y, Nakadate H, Kondoh K, Nakamura K, Koh K, Manabe A
Abstract excerpt
6-Mercaptopurine (6-MP) is a main component of childhood acute lymphoblastic leukemia (ALL) treatment. Some candidate gene variants are associated with its toxicities, but the major variants and effects of combined variants remain unclear. We used Cox regression analysis to evaluate the time-depe...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
